Gonzales Gustavo F, Gasco Manuel, Tapia Vilma, Gonzales-Castañeda Cynthia
Laboratory of Endocrinology and Reproduction, Faculty of Sciences and Philosophy, "Alberto Cazorla Tálleri" Universidad Peruana Cayetano Heredia, Ave. Honorio Delgado 430, Lima 31, Peru.
Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1319-25. doi: 10.1152/ajpendo.90940.2008. Epub 2009 Mar 24.
Chronic mountain sickness (CMS) is characterized by excessive erythrocytosis (EE) secondary to hypoventilation. Erythropoietin (Epo) and testosterone regulate erythrocyte production. Low thyroid hormone levels are also associated to hypoventilation. Hence, these hormones can play a role in etiopathogeny of EE. The purpose of this study was to elucidate the effect of sexual and thyroid hormones and Epo in residents from Lima (150 m) and Cerro de Pasco (4,340 m), Peru, and the response to human chorionic gonadotrophin stimulation (hCG). Three groups, one at low altitude and two at high altitude [1 with hemoglobin values >16-21 g/dl and the second with Hb >or=21 g/dl (EE)], were studied. hCG was administered intramuscularly in a single dose (1,000 IU), and blood samples were obtained at 0, 6, 12, 24, 48, and 72 h after injection. High-altitude natives present similar levels of gonadotropins and thyroid hormones but lower dehydroepiandrosterone sulphate (DHEAS) levels (P < 0.01) and greater Epo (P < 0.01), 17alpha-hydroxyprogesterone (P < 0.01), and testosterone levels (P < 0.01) than those at 150 m. Serum testosterone levels (524.13 +/- 55.91 microg/dl vs. 328.14 +/- 53.23 ng/dl, means +/- SE; P < 0.05) and testosterone/DHEAS ratios are higher (7.98 +/- 1.1 vs. 3.65 +/- 1.1; P < 0.01) and DHEAS levels lower in the EE group (83.85 +/- 14.60 microg/dl vs. 148.95 +/- 19.11 ug/dl; P < 0.05), whereas Epo was not further affected. Testosterone levels were highest and DHEAS levels lowest in the EE group at all times after hCG stimulation. In conclusion, high androgen activity could be involved in the etiopathogeny of CMS. This evidence provides an opportunity to develop new therapeutic strategies.
慢性高山病(CMS)的特征是继发于通气不足的红细胞增多症(EE)。促红细胞生成素(Epo)和睾酮调节红细胞生成。甲状腺激素水平低也与通气不足有关。因此,这些激素可能在EE的发病机制中起作用。本研究的目的是阐明性激素、甲状腺激素和Epo对秘鲁利马(海拔150米)和塞罗德帕斯科(海拔4340米)居民的影响,以及对人绒毛膜促性腺激素刺激(hCG)的反应。研究了三组人群,一组在低海拔地区,两组在高海拔地区[一组血红蛋白值>16 - 21 g/dl,另一组Hb≥21 g/dl(EE)]。单次肌肉注射hCG(1000 IU),并在注射后0、6、12、24、48和72小时采集血样。高海拔地区的本地人促性腺激素和甲状腺激素水平相似,但硫酸脱氢表雄酮(DHEAS)水平较低(P < 0.01),Epo(P < 0.01)、17α-羟孕酮(P < 0.01)和睾酮水平较高(P < 0.01),与海拔150米处的人相比。EE组血清睾酮水平(524.13±55.91μg/dl对328.14±53.23 ng/dl,均值±标准误;P < 0.05)和睾酮/DHEAS比值更高(7.98±1.1对3.65±1.1;P < 0.01),DHEAS水平更低(83.85±14.60μg/dl对148.95±19.11μg/dl;P < 0.05),而Epo未受到进一步影响。在hCG刺激后的所有时间里,EE组睾酮水平最高,DHEAS水平最低。总之,高雄激素活性可能参与CMS的发病机制。这一证据为开发新的治疗策略提供了机会。